Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy-Reference-Cited by-同舟云学术

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy

Published:2021-03 Issue:3 Volume:29 Page:1199-1213
ISSN:1525-0016
Container-title:Molecular Therapy
language:en
Short-container-title:Molecular Therapy

Author:

Dillard Pierre,Köksal Hakan,Maggadottir Solrun Melkorka,Winge-Main Anna,Pollmann Sylvie,Menard Mathilde,Myhre Marit Renée,Mælandsmo Gunhild M.,Flørenes Vivi Ann,Gaudernack Gustav,Kvalheim Gunnar,Wälchli Sébastien,Inderberg Else Marit^ORCID

Funder

Helse Sør-Øst RHF

Norges Forskningsråd

Publisher

Elsevier BV

Subject

Drug Discovery,Pharmacology,Genetics,Molecular Biology,Molecular Medicine

Reference64 articles.

1. Chimeric antigen receptor T cells for sustained remissions in leukemia;Maude;N. Engl. J. Med.,2014

2. T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial;Lee;Lancet,2015

3. Reassessing target antigens for adoptive T-cell therapy;Hinrichs;Nat. Biotechnol.,2013

4. A second chance for telomerase reverse transcriptase in anticancer immunotherapy;Zanetti;Nat. Rev. Clin. Oncol.,2017

5. Telomerase, cell immortality, and cancer;Harley;Cold Spring Harb. Symp. Quant. Biol.,1994

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vaccine-based immunotherapy and related preclinical models for glioma;Trends in Molecular Medicine;2024-07

2. Targeting Telomere Dynamics as an Effective Approach for the Development of Cancer Therapeutics;International Journal of Nanomedicine;2024-04

3. Characterization of atypical T cells generated during ex vivo expansion process for T cell-based adoptive immunotherapy;Frontiers in Immunology;2024-03-13

4. The recent advancement of TCR-T cell therapies for cancer treatment;Acta Biochimica et Biophysica Sinica;2024-03-01

5. An EBV-related CD4 TCR immunotherapy inhibits tumor growth in an HLA-DP5+ nasopharyngeal cancer mouse model;Journal of Clinical Investigation;2024-02-27